dealing with adverse events and toxicities in car-t
Published 4 years ago • 262 plays • Length 22:15Download video MP4
Download video MP3
Similar videos
-
22:15
dealing with adverse events and toxicities in car-t
-
21:53
management of adverse events with newer therapeutic approaches
-
21:59
monitoring, managing, and mitigating immune-related adverse events
-
16:29
car-t: management of cytokine release syndrome and neurotoxicity
-
1:28
assessment of car-t and tcr adverse events
-
24:31
immunological approaches: cars to armored cars - t cell treatment of cancer
-
1:01
advice for physicians treating patients with car-t: monitoring for adverse events
-
22:27
what does the future hold with car-t cell therapy?
-
24:24
car-t therapy in lymphoma and cll
-
51:28
car t-cell in lymphoma
-
21:03
who should receive car-t cell therapy for lymphoma?
-
7:51
managing car t-cell therapy toxicity
-
2:00
leslie popplewell, md, facp, on the management of adverse events associated with car t-cell therapy
-
25:17
who will receive car-t cell therapy in b-cell lymphoma in the near future?
-
16:49
car t-cell therapy in lymphoma: preparation, communication, and aftercare
-
56:49
webinar: car t cell therapy
-
33:05
debate: watch and wait in follicular lymphoma: should we treat immediately?
-
24:16
chronic lymphocytic leukemia: update on car-t cells
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells